Shares of Yumanity Therapeutics, Inc. (NASDAQ:YMTX – Get Free Report) shot up 20.5% on Tuesday . The company traded as high as $0.74 and last traded at $0.63. 832,435 shares traded hands during mid-day trading, an increase of 76% from the average session volume of 473,083 shares. The stock had previously closed at $0.53.
Yumanity Therapeutics Stock Up 20.5 %
The stock has a market cap of $6.89 million, a price-to-earnings ratio of -0.21 and a beta of 0.32. The business’s fifty day moving average is $1.06 and its two-hundred day moving average is $2.59.
Yumanity Therapeutics Company Profile
Yumanity Therapeutics Inc, a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration.
Recommended Stories
- Five stocks we like better than Yumanity Therapeutics
- What is Insider Trading? What You Can Learn from Insider Trading
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Stock Average Calculator
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Yumanity Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yumanity Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
